News

Greystone Secures $451.6 Million Healthcare Financing Round

Greystone Secures $451.6 Million Healthcare Financing Round

Introduction to Greystone's Recent Achievement

Greystone, a national leader in commercial real estate finance, recently celebrated the closing of Greystone CRE Notes 2025-HC4, a remarkable $451.6 million Commercial Real Estate Collateralized Loan Obligation (CRE CLO). This financing is exclusively backed by bridge loans that Greystone has provided for healthcare properties, showcasing their deep commitment to this vital sector.

Significance of the GRE CLO

This closing marks Greystone's eighth CRE CLO. What sets this apart is it being the fourth instance in the industry where a CRE CLO has been entirely comprised of healthcare assets, with previous ones established by Greystone in earlier years. Specifically, this CLO pools together 12 whole loans and 7 loan participations, amounting to a total of 46 properties secured in 13 diverse states.

Portfolio Insights

The portfolio features an impressive range of facilities including skilled nursing, assisted living, memory care, and independent living properties. Notably, skilled nursing homes constitute the majority of the portfolio, equaling around 65.2%, while assisted living and memory care facilities make up approximately 25%. The remaining 9.8% incorporates skilled nursing and assisted living properties.

Trust and Investors' Confidence

Ross Gusler, the Head of Corporate Finance and Capital Markets at Greystone, expressed that this transaction reflects their disciplined healthcare lending approach and the strong faith investors have in their ability as a consistent CLO issuer. Greystone’s continuous growth in the healthcare finance sector illustrates the trust they've built in the market and their dedication to devising impactful capital solutions.

Greystone's Experience in Bridge Lending

With over two decades of expertise in bridge lending, Greystone has earned a reputation for delivering timely capital solutions specifically tailored to the healthcare and multifamily sectors. They have an efficient Bridge-to-Agency lending platform that has successfully delivered $15.1 billion in short-term loans aimed at both healthcare and multifamily needs. Greystone is also recognized as a leading provider of HUD loans in these sectors and ranks highly among Fannie Mae and Freddie Mac lenders.

Enhanced Service Offerings

Greystone doesn’t just facilitate loan provision; their participation within the broader commercial mortgage market includes sales advisory services, asset management, and various ownership and operational activities.

Collaborators in the Transaction

The successful structuring of Greystone CRE Notes 2025-HC4 was managed by ATLAS SP Securities as the sole structuring agent. Prominent financial institutions like Wells Fargo Securities, Goldman Sachs & Co., and J.P. Morgan also played pivotal roles as lead managers in this transaction.

Conclusion

This great feat reaffirms Greystone’s position as a pioneer in commercial real estate finance, leveraging its resources and expertise to propel the healthcare market further. The ongoing success and initiatives exhibited by Greystone underline their commitment to enhancing healthcare, supporting businesses, and fostering community wellness, through the provision of financial solutions tailored for the broader healthcare landscape.

Frequently Asked Questions

What is a CRE CLO?

A Commercial Real Estate Collateralized Loan Obligation (CRE CLO) is a structured finance product that provides funding secured by a pool of commercial real estate loans.

How does Greystone support the healthcare sector?

Greystone supports the healthcare sector by providing timely and accessible financing solutions specifically designed for healthcare properties.

What types of properties does Greystone focus on?

Greystone primarily focuses on skilled nursing, assisted living, memory care, and independent living properties, among others in the healthcare market.

Who were the key players in this financing deal?

ATLAS SP Securities was the structuring agent, with Wells Fargo, Goldman Sachs, and J.P. Morgan serving as lead managers and joint bookrunners.

How has Greystone performed in the multifamily lending sector?

Greystone is recognized as a top provider of financing solutions in the multifamily sector, consistently ranking among the leading lenders for HUD, Fannie Mae, and Freddie Mac loans.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 179

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 311

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 200

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 477

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 0

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

LanzaJet Partners with Fluor for Innovative Sustainable Aviation Fuel Project

Updated Category News Views 255

LanzaJet Collaborates with Fluor Corporation for Project Speedbird CHICAGO — LanzaJet, Inc., a frontrunner in the sustainable fuels technology sector, has announced its partnership with Fluor Corporation for the Front-End Engineering and Design (FEED) of Project Speedbird. This cutting-edge initiative will focus on developing a commercial-scale ethanol-to-sustainable...

Continue Reading
Remarkable Gains of Pippin and AB Tokens Amid Crypto Losses

Updated Category News Views 117

Understanding the Cryptocurrency Market Disruptions In a tumultuous year for large-cap cryptocurrencies, many investors found themselves disheartened by the significant declines in values. However, amidst these struggles, two lesser-known tokens made an unexpected leap, capturing the financial world's attention with stunning performances. The Unprecedented Surge of Pippin...

Continue Reading
Celebrate Spring with Unforgettable Experiences at Grande Lakes

Updated Category News Views 198

Experience the Magic of Spring at Grande Lakes Orlando The changing of seasons brings a wonderful opportunity to celebrate, and there’s no better place to embrace the spirit of spring than at Grande Lakes Orlando. Nestled within a lush landscape, this expansive resort offers a perfect blend of adventure, relaxation, and luxury. Visitors can indulge in a variety of...

Continue Reading
NASA's SpaceX Crew-9 Astronauts Share Insights from Space Mission

Updated Category News Views 365

NASA's SpaceX Crew-9 Astronauts Share Mission Insights After an extensive mission aboard the International Space Station (ISS), the NASA astronauts from the SpaceX Crew-9 will gather for a post-flight news conference. The event is set to offer a unique opportunity to delve into the rich scientific endeavors undertaken during their extraordinary stay in space. The...

Continue Reading
Essity Achieves EcoVadis Platinum Medal for Sustainability Excellence

Updated Category News Views 167

Essity Recognized for Sustainability Leadership Essity, a global leader in hygiene and health solutions, has been awarded the prestigious Platinum medal by EcoVadis for its outstanding performance in sustainability. This achievement places the company in the top 1% of all assessed companies worldwide, reflecting its dedication to responsible business practices. Strong...

Continue Reading